FDA approves drugs for cough, dysmenorrhea

02/28/2013 | RTT News

Hawthorn Pharmaceuticals gained federal approval for its VITUZ oral solution to treat cough and upper respiratory allergies in adults. Cypress Pharmaceuticals also received final approval for its mefenamic acid capsules USP, a generic version of Ponstel Capsules, to address mild-to-moderate pain with primary dysmenorrhea. Hawthorn and Cypress were subsidiaries of Pernix Therapeutics Holdings.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN